LX-4211 is a potent dual sodium-glucose cotransporter (SGLT)1 and SGLT2 inhibitor and an anti-diabetic agent. Sotagliflozin signific antly improves glycemic control, without increasing the rate of hypoglycemia measurements, in diabetic mice maintaine

Numéro d'article : BIOV9623-25

Unité de mesure : 25 MG

820.00 CHF 820.0 CHF 820.00 CHF

820.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Fabricant : BIOVISION

Numéro du fabricant : 9623-25

Température de stockage : Freezer (-20)

LX-4211 is a potent dual sodium-glucose cotransporter (SGLT)1 and SGLT2 inhibitor and an anti-diabetic agent. Sotagliflozin signific antly improves glycemic control, without increasing the rate of hypoglycemia measurements, in diabetic mice maintaine

LX-4211 is a potent dual sodium-glucose cotransporter (SGLT)1 and SGLT2 inhibitor and an anti-diabetic agent. Sotagliflozin signific antly improves glycemic control, without increasing the rate of hypoglycemia measurements, in diabetic mice maintaine

820.00 CHF 820.0 CHF 820.00 CHF

820.00 CHF

Not Available For Sale